Amyloid PET in the Age of Therapy: Precision, Practicality, and Systemic Hurdles
Central question: With anti-amyloid therapies on the menu, does amyloid PET scanning deliver enough diagnostic and therapeutic precision to justify its complexity, cost, and infrastructural demands?
What this might mean
The authors see amyloid PET as a decisive diagnostic and monitoring tool that can reduce wasteful or risky treatments in selected patients. Its main utility may lie in resolving equivocal cases and managing therapy more adaptively. Yet, capacity constraints, cost, and regional disparities keep this from being a general solution. The value of amyloid PET depends as much on organizational design and triage protocols as on technical merit.